Lv12
8 积分 2023-10-24 加入
Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy
2小时前
已完结
Preliminary Results from a Phase I/II Study of Pomalidomide Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (PRIDE)
6小时前
已完结
Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B-cell lymphoma
10小时前
已完结
Primary Large B-cell Lymphomas of Immune-Privileged Sites
1天前
已完结
DLBCL: Who is high risk and how should treatment be optimized?
1天前
已完结
CD34-positive pleomorphic uterine sarcoma with NUDT3::RAD51B fusion
4个月前
已完结
[Disease burden of liver cancer in the Chinese population, in 1990 and 2013]
5个月前
已完结
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides
5个月前
已完结
Real-world outcomes in patients with biomarker-selected early-stage non-small cell lung cancer
6个月前
已关闭
Lung cancer
6个月前
已完结
皖公网安备34019202002308
